ArticleThe Canadian journal of hospital pharmacy2025

Risk of Cytomegalovirus Infection after 3 or 6 Months of Valganciclovir Prophylaxis among Donor-Seropositive, Recipient-Seronegative Heart Transplant Recipients.

Vincent Leclerc et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.